| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 54.7924 | 59 |
| GSM780708 | Untreated after 4 days (C2_1) | 54.4172 | 59 |
| GSM780709 | Untreated after 4 days (C3_1) | 49.2167 | 46 |
| GSM780719 | Untreated after 4 days (C1_2) | 50.8716 | 51 |
| GSM780720 | Untreated after 4 days (C2_2) | 41.9684 | 13 |
| GSM780721 | Untreated after 4 days (C3_2) | 51.7004 | 53 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 50.5564 | 50 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 61.4871 | 65 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 47.8315 | 40 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 51.9996 | 54 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 43.918 | 22 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 48.0691 | 41 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 52.68 | 55 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 49.6554 | 47 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 53.8625 | 58 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 45.1901 | 28 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 54.5789 | 59 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 47.9234 | 41 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 53.7833 | 58 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 53.3667 | 57 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 44.4034 | 24 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 46.5041 | 34 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 56.1022 | 61 |